Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol Myers Squibb Company (NYSE:BMY) to Release Q4 Earnings January 28
TransWorld News
Saturday, January 9, 2010 - 1:00pm
tags:
Bristol-Myers Squibb
OncoGenex Pharmaceutical Downward Momentum Looks to Continue (OGXI)
Comtex Smartrend
Saturday, January 9, 2010 - 12:58pm
tags:
OncoGenex
Kindler reveals some do's and don't's for Pfizer
The Day
Saturday, January 9, 2010 - 12:55pm
tags:
Pfizer
Teva sees revenue more than doubling by 2015
Reuters
Saturday, January 9, 2010 - 12:53pm
tags:
Teva Pharmaceuticals
Sopherion gets US FDA fast track status for Myocet in metastatic breast cancer
Pharmabiz
Saturday, January 9, 2010 - 12:51pm
tags:
Sopherion, Myocet, breast cancer
Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
Trading Markets
Saturday, January 9, 2010 - 12:50pm
tags:
Novelos Therapeutics, lung cancer
Despite FDA Recommendation for Postmarketing Surveillance, Amgen's Prolia Will Achieve Blockbuster Sales for Treatment of Osteoporosis
Trading Markets
Saturday, January 9, 2010 - 12:48pm
tags:
Prolia, osteoporosis, Amgen
Elixir Announces First Sirtuin Inhibitor Clinical Trial
Trading Markets
Saturday, January 9, 2010 - 12:46pm
tags:
Elixir Medical
China Medicine Corporation Enters Into a $69.6 Million Financing Agreement with One Equity Partners
Trading Markets
Saturday, January 9, 2010 - 12:45pm
tags:
China Medicine Corporation
Pfizer and Strides Arcolab form partnership for generic products
Trading Markets
Saturday, January 9, 2010 - 12:43pm
tags:
Pfizer, Strides Arcolab
Watson Laboratories Inc files ANDA with FDA for generic Nuvigil
Trading Markets
Saturday, January 9, 2010 - 12:42pm
tags:
Watson Pharmaceuticals, NUVIGIL
China Sky One Medical Inc lists on NASDAQ Global Select Market
Trading Markets
Saturday, January 9, 2010 - 12:41pm
tags:
China
The Wrong Story About Depression
NY Times
Saturday, January 9, 2010 - 12:40pm
tags:
depression
Biovel Lifesciences may be bought over by Ranbaxy for about Rs.50 cr
Pharmabiz
Saturday, January 9, 2010 - 12:20pm
tags:
Biolevel LifeSciences, Ranbaxy
Roche Wins U.S. Approval for Arthritis Drug Actemra
BusinessWeek
Saturday, January 9, 2010 - 12:17pm
tags:
Roche, Actemra
Abbott's Stent Struggling to Maintain Market Share
Minyanville
Saturday, January 9, 2010 - 11:58am
tags:
Abbott Laboratories, stents
Teva and the Narrowing Gap Between Generics and Big Pharma
Wall Street Journal
Saturday, January 9, 2010 - 11:57am
tags:
Teva Pharmaceuticals
CSI: Trimeris-Arigene
NY Times
Saturday, January 9, 2010 - 11:55am
tags:
Trimeris, Arigene
Emergent BioSolutions lowers its debt payments
bizjournals.com
Saturday, January 9, 2010 - 11:27am
tags:
Emergent BioSolutions
Vical Secures $25 Million Issuer Managed Equity Facility With Azimuth Opportunity, Ltd.
Yahoo
Saturday, January 9, 2010 - 11:25am
tags:
Vical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.